TEVA 7335 (Topiramate (Sprinkle) 15 mg)
Pill with imprint TEVA 7335 is White, Capsule-shape and has been identified as Topiramate (Sprinkle) 15 mg. It is supplied by Teva Pharmaceuticals USA.
Topiramate is used in the treatment of epilepsy; lennox-gastaut syndrome; migraine prevention; seizure prevention; seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 15 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TEVA 7335
Topiramate (Sprinkle)
- Imprint:
- TEVA 7335
- Strength:
- 15 mg
- Color:
- White
- Size:
- 18.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00093-7335
More about topiramate
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 1079 Reviews
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- FDA Alerts (3)
Consumer resources
- Topiramate
- Topiramate Extended-Release Sprinkle Capsules
- Topiramate Tablets
- Topiramate Extended-Release Capsules
- Topiramate Sprinkle Capsules
- Topiramate (Advanced Reading)
Other brands: Topamax, Trokendi XR, Qudexy XR, Topamax Sprinkle, Topiragen
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
